WIR SIND FÜR DICH DA! Wir setzen alles daran unser Lieferversprechen einzuhalten.

The Role of the Extracellular Matrix in Axonal Regeneration and its Treatment after Spinal Cord Injury

von Barbara Grimpe - Verkauft von myWorld
Zustand: Neu
UVP: CHF 61.00
CHF 55.15
Ersparnis: CHF 5.85 (10%)
Barbara Grimpe The Role of the Extracellular Matrix in Axonal Regeneration and its Treatment after Spinal Cord Injury
The Role of the Extracellular Matrix in Axonal Regeneration and its Treatment after Spinal Cord Injury
Barbara Grimpe - The Role of the Extracellular Matrix in Axonal Regeneration and its Treatment after Spinal Cord Injury
CHF 55.15 inkl. USt.
Nur noch 1 Stück verfügbar Nur noch 3 Stück verfügbar
Lieferung: zwischen 5 - 7 Werktagen
Verkauf & Versand: myWorld
Verkauft von myWorld. Bitte klicke auf den Namen des Verkäufers um folgende Informationen zu erhalten: Impressum, AGB‘s, Datenschutzerklärung, Widerrufsrecht und Lieferbedingungen.

Beschreibung

The suffering and tragedy associated with regeneration failure of the central nervous system (CNS) has spurred medical research for over a century. The extracellular matrix (ECM) assumes an essential function during such regeneration processes because it provides the surface for elongating axons and neuritis, stabilizes the synapses and confines further damage by forming the lesion scar. The development of easy to administer therapeutics in the treatment of acute spinal cord injury (SCI) is a long awaited intervention in the pursuit of finding a cure for paralysis. Therefore, this thesis summarizes investigations on ECM molecules such as nidogen-1, laminin gamma-1-chain, xylosyltransferase-1 (XT-1) and CD44osteopontin (OPN) interaction important during cell adhesion and regeneration processes. To respond to the pressing need of new therapeutics a knock down technology called deoxyribozymes or DNA enzymes were tested in various cell culture and animal experiments, which generated such potential drugs. Animals that received systemic administration of a DNA enzyme to XT-1 after a contusion injury of the thoracic spinal cord resulted in a significant improvement of sensorimotor function and increased serotonergic axon presence caudal to the injury, had no toxicological and pathological effects and neuropathic pain was not observed. Collectively, this demonstrates that the DNA enzyme technology generates safe neurotherapeutic, which hold promise to become an integral component of therapies that aim to improve the quality of life of persons with SCI.

Mitwirkende

Autor Barbara Grimpe

Produktdetails

DUIN VVQA1JN42JP

GTIN 9783844025231

Erscheinungsdatum 01.01.2014

Sprache Englisch

Produkttyp Buch

Größe 210 x 148  mm

Produktgewicht 227 g

CHF 55.15
play pause
Als Cashback Mitglied erhältst du bei diesem Einkauf Geld zurück und kannst wertvolle Shopping Points sammeln. Bist du noch kein Mitglied?
Mehr erfahren
Wir nutzen Cookies auf unserer Website, um deinen Besuch effizienter zu gestalten und dir mehr Benutzerfreundlichkeit bieten zu können. Klicke daher bitte auf "Cookies akzeptieren"! Nähere Informationen findest du in unserer Datenschutzerklärung.